Journal article Open access Published 2025
Ruthenium-enhanced curcumin derivatives target tumor growth and cancer-related inflammation in head and neck cancer models
Frontiers in Oncology 15, 1708944 (2025)
- 2025 Year
- 41479792 PMID
Cite this publication
VESELA, K., A. TATAR, Z. KEJIK, N. ABRAMENKO, R. KAPLANEK, P. BABULA, K. KUCNIROVA, J. HAJDUCH, P. MARTASEK, M. JAKUBEK: Ruthenium-enhanced curcumin derivatives target tumor growth and cancer-related inflammation in head and neck cancer models. Frontiers in Oncology. 2025, 15, 1708944, ISSN: 2234-943X, PMID: 41479792, PDF.
Details
- ISSN
- 2234-943X